Back to 
Assenagon Asset Management S.A.
Assenagon Asset Management S.A.
BBIO
Showing 9 of 21 quarters
Position history for Assenagon Asset Management S.A.'s holdings in BridgeBio Pharma, Inc.
Yes. Assenagon Asset Management holds 14,444 shares of BBIO (BridgeBio Pharma), worth $950,415, as of its Q3 2026 13F filing. It reduced the position by 1,176 shares (-7.5%) from Q2 2026. Assenagon Asset Management has held BBIO since Q3 2021, across 21 quarterly 13F filings.
Current Value
$950,415
Current Shares
14,444
Total Value Change
+$335,963
Total Shares Change
-9,690
Quarter-by-Quarter History